RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing.
Wilkins D, Wählby-Hamrén U, Chang Y, Clegg LE, Domachowske J, Englund JA, Muller WJ, Leach A, Kelly EJ, Villafana T.
Wilkins D, et al.
Pediatrics. 2024 Oct 1:e2024067174. doi: 10.1542/peds.2024-067174. Online ahead of print.
Pediatrics. 2024.
PMID: 39350745